Mean intraocular pressure and progression based on corneal thickness in patients with ocular hypertension

Eye (Lond). 2009 Jan;23(1):73-8. doi: 10.1038/sj.eye.6702995. Epub 2007 Oct 5.

Abstract

Purpose: To determine the incidence of glaucomatous progression at mean intraocular pressure (IOP) levels in patients with ocular hypertension (OHT).

Methods: A retrospective, multicentre, cohort analysis of 230 OHT patients with 5 years of follow-up evaluated for risk factors associated with progressive optic disc and visual field loss to determine the incidence of glaucomatous progression.

Results: Forty percent of patients with IOPs > or = 24 mmHg, 18% of patients with IOPs of 21-23 mmHg, 11% of patients with IOPs with 18-20 mmHg, and 3% of patients with IOPs of < or = 17 mmHg progressed to glaucoma. The mean IOP was 19.8+/-2.4 mmHg in the stable group and 21.7+/-2.6 mmHg in the progressed group (P=0.0004). The highest average peak IOP was 23.4+/-4.0 mmHg in the stable group and 25.2+/-3.1 mmHg in the progressed group (P=0.006). Based on the pachymetry values for central corneal thickness, patients with thinner corneas more often progressed to glaucoma (P<0.0001). A multivariant regression analysis to determine risk factors for progression was positive primarily for higher peak IOPs, older age, male gender, argon laser trabeculoplasty, visual acuity > or = 20/50, and no topical medical therapy or beta-blocker therapy prior to the study.

Conclusions: IOP reduction within the normal range over 5 years of follow-up reduces the chance of progression to primary open-angle glaucoma in OHT patients.

Publication types

  • Clinical Trial
  • Multicenter Study

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Adult
  • Aged
  • Cornea / anatomy & histology*
  • Disease Progression
  • Female
  • Glaucoma / physiopathology
  • Glaucoma / prevention & control
  • Humans
  • Intraocular Pressure / physiology*
  • Male
  • Middle Aged
  • Ocular Hypertension / pathology
  • Ocular Hypertension / physiopathology*
  • Regression Analysis
  • Retrospective Studies
  • Risk Factors
  • Trabeculectomy / statistics & numerical data
  • Visual Acuity / physiology
  • Young Adult

Substances

  • Adrenergic beta-Antagonists